Related Publications
- A fluorometric assay to determine the protective effect of glucose-6-phosphate dehydrogenase (G6PD) against a Plasmodium spp. infection in females heterozygous for the G6PD gene: proof of concept in Plasmodium falciparum
- A molecular barcode and web-based data analysis tool to identify imported Plasmodium vivax malaria
- A Review of the Current Status of G6PD Deficiency Testing to Guide Radical Cure Treatment for Vivax Malaria
- Acceptability and feasibility of glucose-6-phosphate dehydrogenase (G6PD) testing using SD Biosensor by village malaria workers in Cambodia: a qualitative study
- Adherence to 14-day radical cure for Plasmodium vivax malaria in Papua, Indonesia: a mixed-methods study
- An open dataset of Plasmodium vivax genome variation in 1,895 worldwide samples
- Automated reporting of primaquine dose efficacy, tolerability and safety for Plasmodium vivax malaria using a systematic review and individual patient data meta-analysis
- Co-design of a routine clinical review to improve the safety of high dose radical cure treatment for Plasmodium vivax malaria: findings from Cambodia and Ethiopia
- Cost-Effectiveness Analysis of Sex-Stratified Plasmodium vivax Treatment Strategies Using Available G6PD Diagnostics to Accelerate Access to Radical Cure
- Effect of adherence to primaquine on the risk of Plasmodium vivax recurrence: a WorldWide Antimalarial Resistance Network systematic review and individual patient data meta-analysis
- Effectiveness and Safety of High Dose Primaquine and Tafenoquine in Plasmodium vivax Patients (EFFORT) – A Multi-Centre, Open Label, Superiority Randomised Controlled Trial
- Enhanced data quality to improve malaria surveillance in Papua, Indonesia
- Genetic Variants of Glucose-6-Phosphate Dehydrogenase and Their Associated Enzyme Activity: A Systematic Review and Meta-Analysis
- Glucose 6 Phosphate Dehydrogenase (G6PD) quantitation using biosensors at the point of first contact: a mixed method study in Cambodia
- Glucose-6-Phosphate Dehydrogenase (G6PD) Measurement Using Biosensors by Community-Based Village Malaria Workers and Hospital Laboratory Staff in Cambodia: A Quantitative Study
- Glucose-6-phosphate dehydrogenase activity in individuals with and without malaria: Analysis of clinical trial, cross-sectional and case-control data from Bangladesh
- Implementation of Glucose-6-Phosphate Dehydrogenase (G6PD) testing for Plasmodium vivax case management, a mixed method study from Cambodia
- Imported malaria and its implication to achievement of malaria-free Bhutan
- Perceptions of shorter radical cure Plasmodium vivax treatment regimens and their implementation: a qualitative study among stakeholders in Cambodia
- Performance of quantitative point-of-care tests to measure G6PD activity: An individual participant data meta-analysis
- Primaquine radical cure in patients with Plasmodium falciparum malaria in areas co-endemic for P falciparum and Plasmodium vivax (PRIMA): a multicentre, open-label, superiority randomised controlled trial
- Primaquine-induced Severe Hemolysis in the Absence of Concomitant Malaria: Effects on G6PD Activity and Renal Function
- Quantification of glucose-6-phosphate dehydrogenase activity by spectrophotometry: A systematic review and meta-analysis
- Quantifying primaquine effectiveness and improving adherence: a round table discussion of the APMEN Vivax Working Group
- Reducing the risk of Plasmodium vivax after falciparum infections in co-endemic areas – a radomised controlled trial
- Safety of single-dose primaquine as a Plasmodium falciparum gametocytocide: a systematic review and meta-analysis of individual patient data
- Short-course primaquine for the radical cure of Plasmodium vivax malaria: a multicentre, randomised, placebo-controlled non-inferiority trial
- Supervised versus unsupervised primaquine radical cure for the treatment of falciparum and vivax malaria in Papua, Indonesia: a cluster-randomised, controlled, open-label superiority trial
- The haematological consequences of Plasmodium vivax malaria after chloroquine treatment with and without primaquine: a WorldWide Antimalarial Resistance Network systematic review and individual patient data meta-analysis
- The heterogeneity of symptom reporting across study sites: a secondary analysis of a randomised placebo-controlled multicentre antimalarial trial
- Variation in Glucose-6-Phosphate Dehydrogenase activity following acute malaria
Benedikt Ley is a public health expert with a focus on diagnostics, Malaria and G6PD deficiency. He started his career in 2008 with the University of Vienna (Austria), based in Bangladesh working on infectious diseases in the Bangladesh / Myanmar border region. He joined the International Vaccine Institute (Korea) based in Zanzibar and subsequently in Kenya focussing on typhoid fever. In 2012 Benedikt joined the Institute of Tropical Medicine, Antwerp (Belgium) where he worked on Salmonella spp. infections and in parallel completed his PhD in 2013 with the University of Vienna on the diagnosis of cholera and typhoid fever. In 2014 Benedikt moved to Darwin, Australia, and joined the Menzies School of Health Research where he focuses on Malaria and G6PD deficiency. He is also a lecturer at the Charles Darwin University and coordinates the Vivax Working Group of the Asia Pacific Malaria Elimination Network (APMEN).